MorphoSys Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 330

Employees

  • Latest Deal Type
  • M&A
  • (Upcoming)

  • Financing Rounds
  • 15

  • Investments
  • 9

MorphoSys General Information

Description

Operator of a biotechnology firm focusing on the research and development of therapeutic antibodies. The company is dedicated to the discovery, development and commercialization of therapies for people living with cancer and autoimmune diseases, enabling patients to lead a healthy life.

Contact Information

Website
www.morphosys.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Semmelweisstrasse 7
  • 82152 Planegg
  • Germany
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Semmelweisstrasse 7
  • 82152 Planegg
  • Germany

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MorphoSys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MorphoSys‘s full profile, request access.

Request a free trial

MorphoSys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology firm focusing on the research and development of therapeutic antibodies. The company is dedi
Biotechnology
Planegg, Germany
330 As of 2024

South San Francisco, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MorphoSys Competitors (72)

One of MorphoSys’s 72 competitors is Sutro Biopharma, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Mersana Therapeutics Formerly VC-backed Cambridge, MA
AnaptysBio Formerly VC-backed San Diego, CA
Innate Pharma Formerly VC-backed Marseille, France
Celldex Therapeutics Formerly VC-backed Hampton, NJ
You’re viewing 5 of 72 competitors. Get the full list »

MorphoSys Patents

  • 814

    Total Documents Applications and Grants

  • Total Patents Families

  • 425

    Granted

  • 111

    Pending

  • Expiring in next 12 mo

MorphoSys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023240297-A1 Deimmunized antibodies specific for cd3 Pending 22-Mar-2022
EP-4496812-A1 Deimmunized antibodies specific for cd3 Pending 22-Mar-2022
AU-2022318255-A1 Combinations of antigen binding molecules Pending 27-Jul-2021
EP-4377347-A1 Combinations of antigen binding molecules Pending 27-Jul-2021
CA-3227537-A1 Combinations of antigen binding molecules Pending 27-Jul-2021 C07K16/2809
To view MorphoSys’s complete patent history, request access »

MorphoSys Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MorphoSys Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MorphoSys‘s full profile, request access.

Request a free trial

MorphoSys Investments & Acquisitions (9)

MorphoSys’s most recent deal was a Early Stage VC with HI-Bio for . The deal was made on 28-Oct-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HI-Bio 28-Oct-2022 Early Stage VC Biotechnology
Constellation Pharmaceuticals 15-Jul-2021 Merger/Acquisition Biotechnology
AdivoVet 19-Jul-2018 Seed Round Other Services (B2C Non-Financial)
Lanthio Pharma 07-May-2015 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Lanthio Pharma (Lanthipeptide Technology) 17-Oct-2014 Merger/Acquisition Discovery Tools (Healthcare)
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

MorphoSys Exits (3)

MorphoSys’s most recent exit was on 28-Oct-2022 from HI-Bio. The exit was categorized as with 4 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
HI-Bio 28-Oct-2022 Completed
  • 4 buyers
AdivoVet 19-Jul-2018 Completed
  • 3 buyers
Bio-Rad Antibodies 11-Jan-2006 Merger/Acquisition Completed
To view MorphoSys’s complete exits history, request access »

MorphoSys Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sloning BioTechnology Puchheim, Germany 2000

MorphoSys FAQs

  • When was MorphoSys founded?

    MorphoSys was founded in 1992.

  • Where is MorphoSys headquartered?

    MorphoSys is headquartered in Planegg, Germany.

  • What is the size of MorphoSys?

    MorphoSys has 330 total employees.

  • What industry is MorphoSys in?

    MorphoSys’s primary industry is Biotechnology.

  • Is MorphoSys a private or public company?

    MorphoSys is a Private company.

  • What is MorphoSys’s current revenue?

    The current revenue for MorphoSys is .

  • How much funding has MorphoSys raised over time?

    MorphoSys has raised $649M.

  • Who are MorphoSys’s investors?

    3i Group, Aberdeen, Atlas Venture, Bayern Kapital, and CDC Participation are 5 of 11 investors who have invested in MorphoSys.

  • Who are MorphoSys’s competitors?

    Sutro Biopharma, Mersana Therapeutics, AnaptysBio, Innate Pharma, and Celldex Therapeutics are some of the 72 competitors of MorphoSys.

  • When was MorphoSys acquired?

    MorphoSys was acquired on 31-Dec-2025.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »